Funding for this research was provided by:
National Natural Science Foundation of China (81673276)
Central South University (2018zzts237)
Received: 18 December 2018
Accepted: 14 October 2019
First Online: 28 October 2019
Ethics approval and consent to participate
: This study was conducted under the approval of the independent Ethics Committee (EC) of the clinical pharmacology Institute of Central South University (CTXY-130041-3-2). The participants who met the inclusion criteria and signed the informed consent were involved.
: Not applicable
: The authors declare that they have no competing interests.